Ambev S.A. filed a Form 6-K with the U.S. Securities and Exchange Commission in October 2026, furnishing its interim consolidated financial statements for the nine-month and three-month periods ended September 30, 2026.

Key Highlights

  • Nine-month net sales: R$64,207,969 thousand for the nine months ended September 30, 2026, compared to R$63,434,834 thousand in the same period of 2025, according to the filing.
  • Nine-month net income: R$11,726,558 thousand for the nine months ended September 30, 2026, versus R$11,458,935 thousand for the same period of 2025, the filing reported.
  • Third-quarter net income: R$4,366,315 thousand for the three months ended September 30, 2026, compared to R$4,863,720 thousand in the same quarter of 2025.
  • Basic earnings per share (nine months): R$0.7349 per common share for the nine-month period ended September 30, 2026, versus R$0.7141 in the prior-year period.
  • Total assets at September 30, 2026: R$141,574,699 thousand, down from R$145,087,151 thousand at December 31, 2025.
  • Total equity at September 30, 2026: R$91,441,947 thousand, compared to R$88,774,781 thousand at December 31, 2025.
  • Cash and cash equivalents: R$19,188,249 thousand as of September 30, 2026, up from R$18,638,228 thousand at December 31, 2025.

Ambev Third-Quarter and Nine-Month 2026 Financial Results: Key Figures and Balance Sheet

According to the Form 6-K filed for the month of October 2026, Ambev S.A. (NYSE:ABEV) reported nine-month net sales of R$64,207,969 thousand, compared to R$63,434,834 thousand in the corresponding nine-month period of 2025. Cost of sales for the nine months reached R$31,170,344 thousand, yielding a gross profit of R$33,037,625 thousand, versus R$32,322,974 thousand a year earlier. For the three months ended September 30, 2026, net sales were R$21,594,570 thousand and gross profit was R$11,006,273 thousand.

The filing disclosed nine-month income from operations of R$16,340,707 thousand, compared to R$16,414,403 thousand for the same period in 2025. Net financial results were a loss of R$1,855,039 thousand for the nine months, an improvement from a loss of R$2,916,360 thousand in the prior-year period. Income tax expenses for the nine months were R$2,792,549 thousand, up from R$2,030,978 thousand in 2025. Net income attributable to equity holders of Ambev for the nine months was R$11,400,571 thousand. Diluted earnings per share for the nine months were R$0.7321, compared to R$0.7109 in 2025.

On the balance sheet, total assets stood at R$141,574,699 thousand as of September 30, 2026. Total liabilities declined to R$50,132,752 thousand from R$56,312,370 thousand at December 31, 2025. Equity attributable to Ambev's shareholders was R$90,895,723 thousand at September 30, 2026, up from R$87,914,039 thousand at year-end 2025. The filing also noted that as from the fourth quarter of 2025, certain financial income and expense line items "which had previously been presented separately, were combined into the line item 'Other net financial results'," with the same treatment applied on a comparative basis.

What Was Disclosed

Ambev S.A. furnished interim consolidated financial statements covering the nine and three-month periods ended September 30, 2026, including balance sheet, income statement, comprehensive income, and changes in equity, all denominated in thousands of Brazilian Reais.